Cardiac Dimensions Appoints Satya Shreenivas, MD as Chief Medical Officer
Cardiac Dimensions ®, a leader in the development of innovative and minimally invasive treatment modalities to address patients suffering from heart failure with functional mitral regurgitation (FMR), today announced that renowned interventional cardiologist Satya Shreenivas, MD, MBA has joined the company as Chief Medical Officer.
- Cardiac Dimensions ®, a leader in the development of innovative and minimally invasive treatment modalities to address patients suffering from heart failure with functional mitral regurgitation (FMR), today announced that renowned interventional cardiologist Satya Shreenivas, MD, MBA has joined the company as Chief Medical Officer.
- View the full release here: https://www.businesswire.com/news/home/20240116766817/en/
Cardiac Dimensions' new Chief Medical Officer Satya Shreenivas, MD, MBA (Photo: Business Wire)
Dr. Shreenivas brings his rich experience in both the clinical and commercial aspects of the structural heart landscape to his new role with Cardiac Dimensions. - His industry roles have included serving as Chief Medical Officer for HLT Medical, a transcatheter heart valve company, as Chief of Cardiology with Optum/United Health subsidiary SCA Health, and as Medical Director for clinical research organization Medpace.
- Dr. Shreenivas has been instrumental in advising Cardiac Dimensions on its EMPOWER Trial of the Carillon Mitral Contour System®.